Analysts Offer Insights on Technology Companies: Enfusion (ENFN), Vertex (VERX) and Shift4 Payments (FOUR)
Enfusion (ENFN) Gets a Buy From William Blair
Piper Sandler Reaffirms Their Hold Rating on Enfusion (ENFN)
Enfusion's Growth Strategy Met With Sell Rating Amid Market and Strategic Challenges
Analysts' Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)
Stifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)
Enfusion (ENFN) Gets a Hold From Piper Sandler
Analysts Have Conflicting Sentiments on These Technology Companies: Marvell (MRVL) and Enfusion (ENFN)
Enfusion (ENFN) Gets a Buy From William Blair
Enfusion Analyst Ratings
B of A Securities Maintains Underperform on Enfusion, Raises Price Target to $9
Analysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)
William Blair Reaffirms Their Buy Rating on Enfusion (ENFN)
Enfusion Analyst Ratings
Enfusion Stock Sell Rating: Conservative Revenue Growth and Market Challenges Ahead
Enfusion Analyst Ratings
Enfusion (ENFN) Receives a Buy From William Blair
Enfusion Analyst Ratings
UBS Adjusts Enfusion Price Target to $9.50 From $9, Maintains Neutral Rating
William Blair Sticks to Their Buy Rating for Enfusion (ENFN)
No Data